Severe Intraocular Inflammation Mimicking Masquerade Syndrome in a Patient Treated with Dupilumab: A Case Report
Case Reports in Ophthalmology · 18.08.2026 · 17 (1) · 1063-1071
DOI: 10.1159/cop/acaag004 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Ophthalmology, online erschienen am 18.08.2026. Verfasst von Lorenzo Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, "Fondazione Policlinico Universitario A. Gemelli, IRCCS", Rome, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The aim of the study was to report a case of severe vision-threatening intraocular inflammation with exudative retinal detachment presenting as a masquerade syndrome in a patient receiving dupilumab therapy for severe bronchial asthma. Case Presentation: A 51-year-old male with severe bronchial asthma developed sudden-onset no light perception (NLP) vision, iris rubeosis, pupillary seclusion, and total exudative retinal detachment in the right eye during his second cycle of dupilumab treatment. The clinical presentation raised strong suspicion for intraocular malignancy. Comprehensive evaluation including fluorescein and indocyanine green angiography, B-scan ultrasonography, magnetic resonance imaging, and positron emission tomography-computed tomography (PET-CT) was performed. PET-CT demonstrated intense metabolic activity in the right eye (SUV max 19.6) and a pulmonary nodule (SUV max 3.5). Lung biopsy revealed inflammatory changes only, and vitreous sampling excluded malignancy. Dupilumab was discontinued, and systemic and topical corticosteroids were administered. Despite treatment, the eye remained NLP. The course was further complicated by sinusitis and orbital cellulitis, requiring hospitalization. Over more than 12 months of follow-up, the right eye progressed to chronic hypotony and gradual phthisis bulbi. Application of the Naranjo Adverse Drug Reaction Probability Scale yielded a score of 6, classifying the association as probable.
Conclusion
This case represents a severe dupilumab-associated ocular complication. Clinicians prescribing dupilumab should be vigilant for severe ocular adverse events beyond the commonly recognized conjunctivitis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, "Fondazione Policlinico Universitario A. Gemelli, IRCCS", Rome, Italy.
- Department of Ophthalmology, Catholic University "Sacro Cuore", Rome, Italy.
- Ocular Oncology Unit, "Fondazione Policlinico Universitario A. Gemelli, IRCCS", Rome, Italy.
Zitieren
APA
Hu, L., Scupola, A., Caputo, C. G., Pagliara, M. M., Mottola, F., Campaniello, G., Savino, G., Fossataro, C., & Sammarco, M. G. (2026). Severe Intraocular Inflammation Mimicking Masquerade Syndrome in a Patient Treated with Dupilumab: A Case Report. Case Reports in Ophthalmology, 17(1), 1063-1071. https://doi.org/10.1159/cop/acaag004
Vancouver
Hu L, Scupola A, Caputo CG, Pagliara MM, Mottola F, Campaniello G, et al. Severe Intraocular Inflammation Mimicking Masquerade Syndrome in a Patient Treated with Dupilumab: A Case Report. Case Reports in Ophthalmology. 2026;17(1):1063-1071. doi:10.1159/cop/acaag004
BibTeX
@article{Hu2026,
author = {Hu, Lorenzo and Scupola, Andrea and Caputo, Carmela Grazia and Pagliara, Monica Maria and Mottola, Francesco and Campaniello, Giorgia and Savino, Gustavo and Fossataro, Claudia and Sammarco, Maria Grazia},
title = {Severe Intraocular Inflammation Mimicking Masquerade Syndrome in a Patient Treated with Dupilumab: A Case Report},
journal = {Case Reports in Ophthalmology},
year = {2026},
volume = {17},
number = {1},
pages = {1063--1071},
doi = {10.1159/cop/acaag004}
}
EUVIMED